相关实验视频
Updated: Jun 1, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
6.9K
[关于小细胞肺癌免疫治疗的专家共识 (2025年版) ]
Zhonghua zhong liu za zhi [Chinese journal of oncology]
|January 19, 2025
概括
小细胞肺癌 (SCLC) 是具有侵略性的,但新的免疫疗法提供了希望. 免疫检查点抑制剂与化疗相结合,现在是广泛阶段SCLC的标准第一线治疗.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 胸部癌症 胸部癌症 癌症
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有高死亡率的侵袭性神经内分泌瘤.
- 广泛阶段的SCLC (ES-SCLC) 在诊断时占诊断的70%.
- 传统的治疗方法,如化疗和放射治疗对于复发性SCLC的疗效有限.
研究的目的:
- 提供有关SCLC免疫治疗临床应用的专家共识.
- 在SCLC治疗中标准化免疫检查点抑制剂 (ICI) 的使用.
- 为临床医生提供基于当前证据和指导方针的指导.
主要方法:
- "关于SCLC免疫治疗的专家共识 (2025年版) "的制定.
- 审查国内和国际指导方针,共识声明和医学证据.
- 专注于免疫检查点抑制剂 (PD-1/PD-L1) 与化疗结合使用.
主要成果:
- 免疫检查点抑制剂 (ICI) 加上化疗已成为ES-SCLC的新标准第一线治疗方法.
- 在ES-SCLC患者中,ICI显著改善了整体存活率.
- 现在在中国批准了多种ICI,扩大了SCLC患者的治疗选择.
结论:
- 免疫疗法,特别是PD-1/PD-L1抑制剂,代表了SCLC治疗的重大进展.
- 专家的共识旨在指导临床医生优化SCLC免疫疗法.
- 持续的研究和更新的指导方针对于推动SCLC患者护理至关重要.
相关概念视频
Tumor Immunotherapy
468
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
468
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

